Get the Stockscreener App
3.14
0.32%
-0.010
Pre-market:
3.24
0.10
+3.18%
Nrx Pharmaceuticals Inc stock is traded at $3.14, with a volume of 561.02K.
It is down -0.32% in the last 24 hours and up +6.44% over the past month.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
See More
Previous Close:
$3.15
Open:
$3.22
24h Volume:
561.02K
Relative Volume:
1.31
Market Cap:
$62.20M
Revenue:
-
Net Income/Loss:
$-30.15M
P/E Ratio:
-0.785
EPS:
-4
Net Cash Flow:
$-21.66M
1W Performance:
-5.14%
1M Performance:
+6.44%
6M Performance:
+51.69%
1Y Performance:
+159.50%
1-Day Range:
$3.12
$3.3154
1-Week Range:
$3.0484
$3.42
52-Week Range:
$1.12
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Name
Nrx Pharmaceuticals Inc
Sector
Industry
Phone
484-254-6134
Address
1201 ORANGE STREET, WILMINGTON
Compare NRXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
3.14 | 74.88M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.17 | 108.04B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
478.58 | 60.75B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.31 | 61.26B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
829.83 | 50.32B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
164.02 | 33.75B | 398.11M | -1.03B | -868.57M | -5.7032 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | H.C. Wainwright | Buy |
| Apr-02-25 | Initiated | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Stock (NRXP) Latest News
Detecting support and resistance levels for NRx Pharmaceuticals Inc.July 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock go up soonJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - newser.com
Is NRx Pharmaceuticals Inc. meeting your algorithmic filter criteriaTrade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Using AI based signals to follow NRx Pharmaceuticals Inc.Weekly Gains Report & Expert Approved Trade Ideas - newser.com
Market reaction to NRx Pharmaceuticals Inc.’s recent newsInsider Selling & Technical Pattern Based Buy Signals - newser.com
Using AI based signals to follow NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock recover faster than market2025 Technical Overview & Fast Entry High Yield Stock Tips - newser.com
Why NRx Pharmaceuticals Inc. Equity Warrant stock appeals to analystsQuarterly Market Review & Capital Efficiency Focused Strategies - newser.com
Published on: 2025-10-27 23:50:51 - newser.com
Is NRx Pharmaceuticals Inc. stock entering bullish territoryMarket Growth Report & Technical Entry and Exit Alerts - newser.com
Pattern recognition hints at NRx Pharmaceuticals Inc. upside2025 Pullback Review & AI Driven Stock Reports - newser.com
What candlestick patterns are forming on NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Trade Ideas & Fast Gaining Stock Reports - newser.com
Is NRx Pharmaceuticals Inc. stock a safe buy before earningsJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
How NRx Pharmaceuticals Inc. stock reacts to Fed rate cuts2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
Real time breakdown of NRx Pharmaceuticals Inc. stock performanceJuly 2025 Trends & Growth Oriented Trade Recommendations - newser.com
Analyzing drawdowns of NRx Pharmaceuticals Inc. Equity Warrant with statistical toolsWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
NRx Pharmaceuticals (NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market - NewMediaWire
NRx Pharmaceuticals (NASDAQ: NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market - Digital Journal
Visual trend scoring systems applied to NRx Pharmaceuticals Inc.2025 Volatility Report & Expert Curated Trade Setups - newser.com
Using fundamentals and technicals on NRx Pharmaceuticals Inc.Weekly Investment Report & Entry Point Confirmation Signals - newser.com
Using data models to predict NRx Pharmaceuticals Inc. stock movementGap Down & Entry and Exit Point Strategies - newser.com
Why analysts upgrade NRx Pharmaceuticals Inc. Equity Warrant stock2025 Breakouts & Breakdowns & Low Risk High Win Rate Picks - newser.com
Applying Wyckoff theory to NRx Pharmaceuticals Inc. Equity Warrant stockInflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Nrx Pharmaceuticals Inc Stock (NRXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
2.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):